Alpa Laboratories Ltd - 532878 - Consolidated Cash Flow Statement As Required By Exchange
Alpa Laboratories Limited has submitted the consolidated Cash flow Statement for the period ended 30th September, 2019.04-12-2019
04-12-2019
ALPA LABORATORIES LTD. - 532878 - Outcome of Board Meeting
Alpa Laboratories Limited has submitted the financial results for the quarter and half year ended 30th September, 2019.12-11-2019
ALPA LABORATORIES LTD. - 532878 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Alpa Laboratories Ltd has submitted to BSE a copy of Clarification is enclosed.06-11-2019
Alpa Laboratories Ltd - 532878 - Clarification sought from Alpa Laboratories Ltd
The Exchange has sought clarification from Alpa Laboratories Ltd on 05th November, 2019 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.05-11-2019
ALPA LABORATORIES LTD. - 532878 - Board Meeting Intimation for The Standalone And Consolidated Un-Audited Financial Results For Quarter And Half Year Ended 30Th September, 2019.
ALPA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve The Standalone and Consolidated Un-audited Financial Results for quarter and half Year ended 30th September, 2019.31-10-2019
Alpa Laboratories Ltd - 532878 - Certificate Under Regulation 40(9) Of The (Listing Obligations And Disclosure Requirements)Regulation, 2015.
Alpa Laboratories Limited has submitted the Certificate under Regulation 40(9) of the (Listing Obligations and Disclosure Requirements)Regulation, 2015.19-10-2019
Alpa Laboratories Ltd - 532878 - Compliance Certificate Under Regulation 7(3) Of SEBI(LODR),2015 For The Quarter Ended 30Th September, 2019
Alpa Laboratories Limited has submitted the Compliance Certificate under Regulation 7(3) of SEBI(LODR),2015 for the quarter ended 30th September, 2019.12-10-2019
Alpa Laboratories Ltd - 532878 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Alpa Laboratories Limited has submitted the disclosure under Reg. 74(5) of SEBI (DP) Regulations,2018 for quarter ended 30th September,201911-10-2019
ALPA LABORATORIES LTD. - 532878 - Shareholding for the Period Ended September 30, 2019
Alpa Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here09-10-2019
ALPA LABORATORIES LTD. - 532878 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Megha NeemaDesignation :- Company Secretary and Compliance Officer03-10-2019